Table 2 Clinicopathological features of the 59 patients studied
From: Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer
Parameter | No of Cases (%) |
|---|---|
Sex: | Â |
Male | 42 (71.2) |
Female | 17 (28.8) |
Pathological Subtype: | Â |
SCC | 27 (45.8) |
TCC | 27 (45.8) |
Adeno | 5 (8.5) |
Grade: | Â |
I | 5 (8.5) |
II | 39 (66.1) |
III | 15 (25.4) |
Pathological Stage: | Â |
P2 | 3 (5.08) |
P3a | 24 (40.06) |
P3b | 26 (44.06) |
P4 | 6 (10.2) |
Lymph Node Involvement: | Â |
Positive | 10 (16.9) |
Negative | 49 (83.1) |
Local recurrence: | Â |
No | 41 (69.5) |
Yes | 13 (30.5)* |
Metastasis: | Â |
Negative | 46 (78) |
Positive | 8 (22.03)* |
Outcome: | Â |
Dead | 32 (54.2) |
Alive | 27 (45.8) |